This inventor holds 3 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ramkumar Rajamani: Innovator in KRAS Inhibitors
Introduction
Ramkumar Rajamani is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of KRAS inhibitors. His work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
Ramkumar holds 1 patent related to KRAS inhibitors. The patent includes compounds of a specific formula that are designed to inhibit the KRAS protein, which is often mutated in various cancers. This innovation represents a crucial step in targeted cancer therapies.
Career Highlights
Ramkumar Rajamani is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development, focusing on innovative solutions to complex medical challenges. His expertise in medicinal chemistry and drug design has been instrumental in advancing the company's therapeutic offerings.
Collaborations
Ramkumar collaborates with talented professionals in his field, including his coworker Adedoyin David Abraham. Together, they work on groundbreaking research that aims to enhance the efficacy of cancer treatments.
Conclusion
Ramkumar Rajamani's contributions to the field of KRAS inhibitors highlight his dedication to advancing medical science. His work at Eli Lilly and Company exemplifies the impact of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile